Genzyme Corporation (Public, NASDAQ:GENZ)
Genzyme sells new gene test for cystic fibrosis The biotechnology company said the diagnostic test can detect about 98 percent of about 1,200 disease-causing variations in a gene, in which mutations are linked to cystic fibrosis. BioMarin Announces Marketing Approval for Aldurazyme in Japan NOVATO, Calif., Oct. 31 -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that Japan's Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for Aldurazyme(R) (laronidase), the first specific treatment approved in Japan for patients with the genetic disease mucopolysaccharidosis I (MPS I). Aldurazyme was approved in Japan as an orphan drug. "I am very pleased that enzyme replacement therapy with Aldurazyme has finally been approved in Japan for the treatment of MPS I," stated Yoshikatsu Eto, M.D., Chairman and Professor in the Department of Pediatrics at Tokyo Jikei University Hospital located in Tokyo, Japan. "This is an important milestone for Japanese MPS I patients and their treating physicians who now have an effective treatment for this debilitating and life-threatening disease." Aldurazyme was developed in partnership between BioMarin and Genzyme and was approved in the United States and the European Union in April and May 2003, respectively. Pursuant to the joint venture, BioMarin is responsible for manufacturing Aldurazyme and Genzyme is responsible for its commercialization. All expenses and profits and are shared equally between the companies. http://tech.groups.yahoo.com/group/biotech-news/ http://www.arizonabiotech.com/ http://famouspeople.wordpress.com/ http://www.arizonabiotech.com/ http://groups.yahoo.com/group/biotech-news/ http://www.arizonaentrepreneurs.com/ http://www.azhttp.com/ Yahoo! Groups Links <*> To visit your group on the web, go to: http://groups.yahoo.com/group/biotech-news/ <*> Your email settings: Individual Email | Traditional <*> To change settings online go to: http://groups.yahoo.com/group/biotech-news/join (Yahoo! ID required) <*> To change settings via email: mailto:[EMAIL PROTECTED] mailto:[EMAIL PROTECTED] <*> To unsubscribe from this group, send an email to: [EMAIL PROTECTED] <*> Your use of Yahoo! Groups is subject to: http://docs.yahoo.com/info/terms/